Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Neurother. 2012 Sep;12(9):1113-24. doi: 10.1586/ern.12.101.

Disease-specific therapy of idiopathic inflammatory demyelinating disorders.

Author information

  • 1Multiple Sclerosis Research Unit, The Ottawa Hospital General Campus, University of Ottawa, Box 606 MS Clinic, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada. mkhoshnam@toh.on.ca

Abstract

Central nervous system idiopathic inflammatory demyelinating disorders are a heterogenous group of diseases that share inflammation and demyelination as key features. Although the exact pathophysiology remains to be fully unveiled, these conditions are challenging to clinicians who seek specific therapeutic options for their patients. For two of these conditions, multiple sclerosis and neuromyelitis optica, there are now several possible therapies in an ever-evolving field. This review will touch on the various idiopathic inflammatory demyelinating disorders and discuss the various treatment options currently available.

PMID:
23039390
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk